Synapse Biomedical

Synapse Biomedical

Synapse Biomedical

Synapse Biomedical offers NeuRx Diaphragm Pacing System (DPS)® which uses neurostimulation technology to help spinal cord injuries.
Founded
2002
Raised
$2.7M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$2,400,000
Venture capital - 2013
$270,000
Seed fund - 2006
Team Size
10+
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Synapse Biomedical makes some noise.